ACTINIUM PHARMACEUTICALS, INC. Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount of $347.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherReconcilingItems · last filed 2026-03-30
- ACTINIUM PHARMACEUTICALS, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2025 was $347.00K, a 55.96% decline from fiscal 2024.
- ACTINIUM PHARMACEUTICALS, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2024 was $788.00K, a 29.61% increase from fiscal 2023.
- ACTINIUM PHARMACEUTICALS, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2023 was $608.00K.
- ACTINIUM PHARMACEUTICALS, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2021 was $486.00K, a 140.59% increase from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount 12 month | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $347.00K 10-K · filed 2026-03-30 | |
| 2024-12-31 | $788.00K 10-K · filed 2026-03-30 | |
| 2023-12-31 | $608.00K 10-K · filed 2025-03-31 | |
| 2021-12-31 | $486.00K 10-K · filed 2022-03-25 | |
| 2020-12-31 | $202.00K 10-K · filed 2022-03-25 | |
| 2019-12-31 | $145.00K 10-K · filed 2021-03-31 | $144.72K 10-K · filed 2020-05-08 |
| 2018-12-31 | $40.05K 10-K · filed 2020-05-08 | |
| 2017-12-31 | $12.85K 10-K · filed 2019-03-15 | |
| 2016-12-31 | $13.63K 10-K · filed 2019-03-15 | $12.26K 10-K · filed 2017-03-16 |
| 2014-12-31 | $526.22K 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |